NCT03066687 - A Study to Determine the Effect of Food on the Pharmacokinetics of Erdafitinib in Healthy Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 14, 2017

Primary Completion Date

May 12, 2017

Study Completion Date

May 12, 2017

Conditions

Healthy

Interventions

DRUG

Erdafitinib

Erdafitinib 9 mg (provided as one 4-mg tablet \[G-024\] and one 5-mg tablet \[G-025\]) will be administered orally on Day 1 in each Treatment Period of assigned sequence.

Trial Locations (1)

68502

Celerion, Lincoln